Huang, Yining; Sharma, Vijay K.; Robinson, Thompson; Lindley, Richard I.; Chen, Xiaoying; Kim, Jong Sung; Lavados Germain, Pablo Manuel; Olavarría, Verónica; Arima, Hisatomi; Fuentes, Sully; Nguyen, Huy Thang; Lee, Tsong-Hai; Parsons, Mark W.; Levi, Christopher; Demchuk, Andrew M.; Bath, Philip M.W.; Broderick, Joseph P.; Donnan, Geoffrey A.; Martins, Sheila; Pontes Neto, Octavio M.; Silva, Federico; Pandian, Jeyaraj; Ricci, Stefano; Stapf, Christian; Woodward, Mark; Wang, Jiguang; Chalmers, John; Anderson, Craig S. (World Stroke Organization, 2015)
RationaleControversy exists over the optimal dose of intravenous (iv) recombinant tissue plasminogen activator (rt-PA) and degree of blood pressure (BP) control in acute ischaemic stroke (AIS). Asian studies suggest low-dose ...
